CareLit Fachartikel
Treatment of Goitre
S. J. Bonnema, L. Hegedüs · Der Nuklearmediziner · 2005 · Heft 02 · S. 96-103
Dokument
1132248
CareLit-ID
Jahr
2005
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Abstract No consensus exists regarding the optimum treatment of benign non-toxic goitre. L-thyroxine suppressive therapy is widely used for treatment of goitre, but there is poor evidence of its efficacy, and the suppression of serum TSH may have serious adverse effects on health. Iodine supplementation is no better than L-thyroxine in comparative trials. Surgery is first choice in large goitres or if malignancy is suspected. Post-surgery, risk of goitre recurrence is inversely correlated with the extent of the operation. 131I therapy results in a one-year goitre reduction of around 50 % in multinodular and 70 %…
Schlagworte
Euthyroid goitre
goitre therapy
levothyroxine therapy
radioiodine therapy
recombinant human TSH
Observation
Der Nuklearmediziner
